Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program. van Pesch V, Bartholomé E, Bissay V, Bouquiaux O, Bureau M, Caekebeke J, Debruyne J, Declercq I, Decoo D, Denayer P, et al. Acta Neurol Belg. 2014 Jun 11. Epub 2014 Jun 11. PMID: 24915752. Abstract CommentRecommendBookmarkWatch